Table 5.
Parameter (mg/dl) | Treatment |
ANOVA (P) | ||||
---|---|---|---|---|---|---|
N | APE-0 | APE-1 | APE-2 | Simv | ||
TC | 50.2±8.76 | 51.8±8.11 | 50.8±8.35 | 42.8±4.87 | 46.8±4.21 | 0.289ns |
TG | 76.4±22.57 | 130±36.57 | 137.4±30.59 | 62.6±29.36 | 64.6±20.01 | 0.064ǂќns |
LDL | 11.0±1.67ab | 13.8±1.17c | 11.8±1.72bc | 8.4±2.42a | 9.8±1.17ab | 0.003** |
HDL | 41.2±5.53b | 32.2±1.95a | 35±2.00a | 40.6±3.37b | 45.8±3.37b | 0.000** |
ќKruskal-Wallis, **ANOVA test P<0.01, Different letters in the same line showed significant difference (P<0.05). N: Normal rats, APE-0: Hyperlipidemic rats without treatment, APE-1 and APE-2: Hyperlipidemic rats received 57 mg/kg BW APE and 114 mg/kg BW, Simv: Hyperlipidemic rats received 3.6 mg/kg BW simvastatin, APE: Apple peel extract, BW: Body weight, NS: Not significant, TC: Total cholesterol, TG: Triglyceride, LDL: Low-density lipoprotein, HDL: High-density lipoprotein